Concepedia

Tomas Fex

TF

22

Publications

983

Citations

16

H-Index

1976

Active since

Affiliations

AstraZeneca (Sweden)(Current)

Umeå University

Active Biotech (Sweden)

Lund University

Linnaeus University

Tomas Fex is an author at AstraZeneca (Sweden) specializing in medicine, natural sciences, and biochemistry.

Top concepts

MedicineNatural SciencesBiochemistryDrug DiscoveryPharmacologyChemistryMedicinal ChemistryEngineeringBioanalysisOrganic Chemistry

Publications per year

1976–2020

22

Publications

22

Synthesis and Biological Evaluation of New 1,2-Dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for Treatment of Autoimmune Disorders: Structure−Activity Relationship

Stig Jönsson, Gunnar Andersson, Tomas Fex et al. · Journal of Medicinal Chemistry · 2004 · 156 citations

Design and Evaluation of Pilicides: Potential Novel Antibacterial Agents Directed Against UropathogenicEscherichia coli

Anette Svensson, Andréas Larsson, Hans Emtenäs et al. · ChemBioChem · 2001 · 135 citations

Engineering, Infectious Disease, Antimicrobial Chemotherapy +17

Clavatadine A, A Natural Product with Selective Recognition and Irreversible Inhibition of Factor XIa

Malcolm S. Buchanan, Anthony R. Carroll, Deborah Wessling et al. · Journal of Medicinal Chemistry · 2008 · 79 citations · Full text

Crystal Structure, Medicinal Chemistry, Inhibitory Activity +14

Weak affinity chromatography as a new approach for fragment screening in drug discovery

Minh‐Dao Duong‐Thi, Elinor Meiby, Maria Bergström et al. · Analytical Biochemistry · 2011 · 74 citations

Fragment Screening, Medicinal Chemistry, Hit Identification +14

Use of 19F NMR spectroscopy to evaluate reactions in solid phase organic synthesis

Anette Svensson, Tomas Fex, Jan Kihlberg · Tetrahedron Letters · 1996 · 61 citations

Chemical Engineering, Engineering, Nmr Spectroscopy +6

Rows per page

1–5 of 22